Consumers who bought certain generic prescription drugs between May 1, 2009 and December 31, 2019 can now file claims from settlements totaling about $96.5 million. Claims close March 8, 2027.
The money comes from multistate antitrust cases alleging that generic drug manufacturers coordinated prices and competition instead of competing independently.
What the Generic Drug Settlements Are About
The states’ lawsuits allege that competing generic drug manufacturers coordinated prices, bids and market shares instead of competing independently.
The litigation grew into multiple lawsuits involving dozens of pharmaceutical companies and individual executives. A 2016 complaint concerned 15 generic drugs, a 2019 case targeted major manufacturers and senior executives, and a 2020 case focused on 80 topical generic drugs.
According to the states, the alleged conduct affected more than 100 drugs in total, including tablets, capsules, creams and ointments used for infections, ADHD, diabetes, cancer, epilepsy, multiple sclerosis, HIV and other conditions.
The states allege that executives at competing companies communicated through phone calls, emails, text messages and industry meetings while coordinating pricing and competition. In some instances, the states say price increases exceeded 1,000 percent.
One example cited by the New York Attorney General is digoxin, a heart medication manufactured by Heritage. The state says its price tripled, leaving some patients paying hundreds of dollars more.
The settling manufacturers deny wrongdoing, and the settlements do not constitute admissions of liability.
Which Companies Have Settled
The current consumer claims process covers settlements with these manufacturers:
| Settling Company | Settlement Amount |
|---|---|
| Apotex | $39.1 million |
| Heritage Pharmaceuticals / Emcure Pharmaceuticals | $10 million |
| Lannett and Bausch | $17.85 million combined |
| Glenmark Pharmaceuticals USA | $29.6 million |
| Total | About $96.5 million |
The companies also agreed to cooperate with the states’ continuing cases and implement antitrust compliance measures.
Who Qualifies
Eligible consumers generally must:
- Have bought at least one drug on the official covered-drug list between May 1, 2009 and December 31, 2019
- Have purchased the drug for personal use rather than resale
- Not have purchased directly from one of the defendant manufacturers
- Not be an officer, director, manager or employee of a defendant
- Currently live in a U.S. state, commonwealth or territory other than Guam or American Samoa
Eligibility is based on where you live when you file, not where you originally bought the prescription.
Which Generic Drugs Are Included
The official list covers more than 100 generic drugs in specific formulations and strengths.
The exact drug, dosage form and strength can matter, so a familiar drug name alone does not necessarily mean every version qualifies.
Consumers should compare their prescription history against the official covered-drug list.
How Much Money Can You Get?
No fixed payment amount has been announced.
Only part of the combined settlement money is allocated to consumers. Settlement funds also cover administration and approved state litigation costs and fees, while other restitution is allocated to state entities. Individual payments will depend on the consumer funds available and the number and value of valid claims.
What Proof You Need
For a standard consumer claim, the states say they do not intend to require proof of purchase beyond a verified statement that you bought a qualifying covered drug.
The states reserve the right to require proof or audit large claims. Pharmacy histories, prescription records, insurer records or receipts may help if additional documentation is requested.
Because the purchase period goes back to May 1, 2009, old pharmacy or insurance records can also help identify the exact drug, dosage form or strength if you no longer remember it.
How to File a Claim
Claims can be filed through AGGenericDrugs.com, the official settlement website.
You can also contact the Settlement Administrator for information or a paper claim form:
Generic Drugs Settlements 8769
P.O. Box 2599
Faribault, MN 55021-9599
Phone: 1-866-290-0182
Email: [email protected]
What Happens Next
After the claim deadline, submitted claims must be reviewed before individual payments can be calculated.
The broader generic drug litigation is still continuing against other manufacturers and executives, so these settlements do not end the states’ cases.
No consumer payment date has been announced.
About This Page
RecallRefunds.com is a consumer information site. We are not the Settlement Administrator, a law firm, a pharmaceutical manufacturer or a government agency. This page summarizes the state attorneys general generic drug settlements and consumer claims process and is general information, not legal advice.